Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT07546331
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Measurement of Body Composition — PROCEDUREBody composition measurements collected pre and post operatively using a bioelectrical impedance analyzer.
- Chart Review — OTHERClinical and surgical data will be collected from the participants medical records.
Study Details
This study compares measurements of body composition to outcomes of breast reconstruction.
Key Dates
- Start date
- Feb 18, 2026
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
Arms
- Arm: Cohort A: Implant-based ReconstructionPatients undergo standard of care implant-based breast reconstruction and body composition measurement on study.
- Arm: Cohort B: Autologous ReconstructionPatients undergo standard of care autologous breast reconstruction and body composition measurement on study.
Primary Outcome Measure
Proportion of Body Composition Measurement Collection [ Time Frame: up to 2 years ]
Central Contacts
- Michael Choi877-827-3222
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California | San Francisco | California | 94143 | 877-827-3222 Merisa Piper, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
By condition
By specialty
By research site
Related Studies
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood SamplesRecruiting · Stanford University · Stanford, California
- Magnetic Resonance Imaging of Breast CancerRecruiting · Stanford University · Stanford, California
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona